Form 4: REGENXBIO Director Buys Shares
Insider Transaction (Form 4)
Gregory Austin Ciongoli, a Director of REGENXBIO Inc., purchased 102,603 shares of common stock on August 25, 2026.
Summary
- Grant/award: acquired 15,432 Common Stock on August 25, 2026; holds 15,432 after (Direct).
- Open-market purchase: acquired 49,196 Common Stock at $9.14 ($449,706) on August 26, 2026; holds 64,628 after (Direct).
- Open-market purchase: acquired 53,407 Common Stock at $9.36 ($499,676) on August 27, 2026; holds 118,035 after (Direct).
- Grant/award: acquired 69,609 Stock Options (Right to buy) on August 25, 2026; holds 69,609 after (Direct).
Sentiment
Score: 8
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $949,381, committing personal capital to the stock.
Insider Transactions
Gregory Austin Ciongoli — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-25 | Grant/award | Common Stock | 15,432 | — | — | 15,432 |
| 2026-08-26 | Open-market purchase | Common Stock | 49,196 | $9 | $449.7K | 64,628 |
| 2026-08-27 | Open-market purchase | Common Stock | 53,407 | $9 | $499.7K | 118,035 |
| 2026-08-25 | Grant/award | Stock Options (Right to buy) | 69,609 | — | — | 69,609 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-25 | Grant/award (15,432 shares) |
| 2026-08-26 | Open-market purchase (49,196 shares) |
| 2026-08-27 | Open-market purchase (53,407 shares) |
| 2026-08-25 | Grant/award (69,609 shares) |
Keywords
insider transaction, Form 4, RGNX, REGENXBIO Inc., bullish, Gregory Austin Ciongoli
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.